AstraZeneca’s troubled vaccine not renewed in EU; Pfizer gets big, new deal
Ars Technica 2021-05-10
Summary:
Meanwhile, China’s Sinopharm vaccine—79% efficacy, easy to store—authorized by WHO.
Link:
https://arstechnica.com/?p=1763808From feeds:
Berkeley Law Library -- Reference & Research Services » Ars Technica » Scientific MethodCyberlaw » Ars Technica
Music and Digital Media » Ars Technica